Multiple Sclerosis Resource Centre Trauma and MS. Hope for MS pill after cladribine and fingolimod tria. Oral drugs to treat multiple sclerosis could become available in 2011 after promising results in two trials. Drug licences have been applied for and the MS Society said it was "great news" for people with MS - current treatments involve injections or infusions.
The trials of the drugs each involved 1,000 people in over 18 countries, the New England Journal of Medicine says. Cladribine and fingolimod, which come as tablets, cut relapse rates by 50-60% over two years compared with placebos.